Wikidata

(Q63322888)

English

Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple Sclerosis

clinical trial

In more languages

Statements

title
A Long-Term, Open-Label, Multicenter, Extension Study to Evaluate Safety and Efficacy of BG00002 in Japanese Subjects With Relapsing-Remitting Multiple Sclerosis (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Japan
0 references
start time
October 2010
0 references
end time
December 2014
0 references
number of participants
97
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63322888&oldid=1857144855"